| Structure |
Chemical Name |
CAS |
MF |
 |
EPZ-6438 (E7438) (EZH2 inhibitor) |
|
|
|
|
EMPAGLIFLOZIN (SGLT inhibitor) |
|
|
|
|
DOXORUBICIN (TOPOISOMERASE inhibitor) |
|
|
|
|
DAPT (Γ-SECRETASE inhibitor) |
|
|
|
|
DACLATASVIR (HCV NS5A inhibitor) |
|
|
|
|
COMBRETASTATIN A4 (MICROTUBULE ASSOCIATED inhibitor) |
|
|
|
|
CLOZAPINE N-OXIDE (5-HT2 antagonist) |
|
|
|
|
CABOZANTINIB (VEGFR inhibitor) |
|
|
|
|
BREFELDIN A (protein transport inhibitor) |
|
|
|
|
BKM120 (PI3K inhibitor) |
|
|
|
|
AZILSARTAN (RAAS antagonist) |
|
|
|
|
AKT INHIBITOR VIII (AKT inhibitor) |
|
|
|
|
ABT-199 (BCL-2 inhibitor) |
|
|
 |
L-741742 Hydrochloride |
874882-93-6 |
C23H26Cl2N2O |
|
|
Kidney function biochemical test kit |
|
|
|
|
Chemiluminescent reagents |
|
|
 |
BAY-545 |
1699717-32-2 |
C18H22F3N3O4S |
|
|
ENDOFECTIN MAX Transfection Reagent |
|
|
|
|
WB primary antibody dilution |
|
|
|
|
WESTERN Antibody Eluent (Strongly Basic) |
|
|
|
|
B-27 serum-free additive, 50X, no vitamin A |
|
|
![3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]-](/CAS/20210305/GIF/2569467-78-1.gif) |
3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]- |
2569467-78-1 |
C19H23ClN4O4S |
 |
Porfiromycin |
801-52-5 |
C16H20N4O5 |
 |
Procinolol |
27325-36-6 |
C15H23NO2 |
 |
thermospermine |
70862-11-2 |
C10H26N4 |
 |
(D-ALA7)-ANGIOTENSIN I/II (1-7) |
159432-28-7 |
C39H60N12O11 |
 |
1-METHYL-NICOTINAMIDE IODIDE |
6456-44-6 |
C7H9IN2O |
 |
Palonosetron |
135729-61-2 |
C19H24N2O |
 |
4-DIMETHYLAMINO-7-(4-ETHYL-PHENYL)-7H-9-THIA-1,5,7-TRIAZA-FLUOREN-8-ONE |
869802-44-8 |
C19H18N4OS |
|
|
People lymphocyte separation fluid |
|
|
 |
BDA-366 |
1909226-00-1 |
C24H29N3O4 |
|
|
Primary Antibody Dilution Buffer |
|
|
![Carbamic acid,N-[2-[[(2,3-dimethylimidazo[1,2-a]pyridin-8-yl)amino]methyl]-3-methylphenyl]-,methyl ester](/CAS/20180529/GIF/158364-59-1.gif) |
Carbamic acid,N-[2-[[(2,3-dimethylimidazo[1,2-a]pyridin-8-yl)amino]methyl]-3-methylphenyl]-,methyl ester |
158364-59-1 |
C19H22N4O2 |
|
|
Cyanine5 amine |
1807529-70-9 |
|
|
|
VINCRISTINE (MICROTUBULE ASSOSIATED inhibitor) |
|
|
|
|
TETRABENAZINE (VMAT-2 Inhibitor) |
|
|
|
|
SNX-2112 (PF-04928473) (HSP90 antimony inhibitor) |
|
|
|
|
S2RA (SIGMA RECEPTOR antagonist) |
|
|
|
|
PUROMYCIN DIHYDROCHLORIDE (Puromycin) |
|
|
|
|
PLX4032 (RAF inhibitor) |
|
|
|
|
PD123319 (RAAS inhibitor) |
|
|
|
|
NS-2028 (SGC inhibitor) |
|
|
|
|
NECROSTATIN-1 (TNF-ALPHA inhibitor) |
|
|
|
|
ML323 (DUB inhibitor) |
|
|
|
|
KU-55933 (ATM inhibitor) |
|
|
|
|
(+)-JQ1 (BRD4 inhibitor) |
|
|
|
|
GSK2141795 (AKT inhibitor) |
|
|
|
|
GANETESPIB (HSP inhibitor) |
|
|
|
|
ENZALUTAMIDE (MDV3100) (AR inhibitor) |
|
|
|
|
BRIVANIB (VEGFR inhibitor) |
|
|
|
|
BARDOXOLONE METHYL (IΚB/IKK inhibitor) |
|
|
|
|
AZ20 (ATM/ATR inhibitor) |
|
|
|
|
ARN-509 (ANDROGEN RECEPTOR Inhibitor) |
|
|
|
|
AM281 (CB1 antagonist) |
|
|
|
|
AC-YVAD-PNA (CASPASE 1 chromogenic substrate) |
|
|
 |
TB500 |
885340-08-9 |
C38H68N10O14 |
|
|
IPHASE Simulated human urine |
|
|
|
|
Glucose metabolism biochemical detection kit |
|
|
 |
FSCPX |
156547-56-7 |
C23H27FN4O6S |
 |
TD-0212 |
1073549-10-6 |
C28H34FN3O4S |
 |
5'-Guanylic acid, 3'-O-methyl- |
400806-41-9 |
C11H16N5O8P |
 |
Guanosine 5'-(trihydrogen diphosphate), 3'-O-methyl- (9CI) |
78771-34-3 |
C11H17N5O11P2 |
 |
N-CIS-2,6-DIMETHYLPIPERIDINOCARBONYL-BETA-TBU-ALA-D-TRP(1-METHOXYCARBONYL)-D-NLE-OH |
173326-37-9 |
C34H51N5O7 |
 |
5-PREGNEN-3BETA-OL-20-ONE-16ALPHA-CARBONITRILE |
1434-54-4 |
C22H31NO2 |
 |
5-HYDROXYTRYPTAMINE MALEATE SALT |
18525-25-2 |
C14H16N2O5 |
![1,4-Dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]amino]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylicacid3,5-dimethylesterL-Lactate](/CAS/GIF/186185-03-5.gif) |
1,4-Dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]amino]phenyl]-2,6-dimethyl-3,5-pyridinedicarboxylicacid3,5-dimethylesterL-Lactate |
186185-03-5 |
C33H42N4O6 |
 |
ML 145 |
1164500-72-4 |
C24H22N2O5S2 |
 |
Gefapixant |
1015787-98-0 |
C14H19N5O4S |